Health Care
More on Health Care
Washington DC —At a hearing today before the House Committee on Oversight and Government Reform, Ranking Member Elijah E. Cummings questioned health and medical experts about "gray market" drug companies that buy and sell drugs in critically short supply at exorbitant prices.
Washington, DC– Today, Rep. Elijah E. Cummings, Ranking Member of the House Committee on Oversight and Government Reform, and Rep. Danny K.
Washington, DC—Today, Ranking Member Elijah E. Cummings sent a second letter to Superior Medical Supply, Inc., requesting documents about the company's purchases and sales of a cancer drug in critically short supply as part of Cummings' broader investigation into so-called "gray market" drug companies.
Read more about Gray Market Investigation and Visit the Tip Line here.
Congressman Danny Davis (D-IL), the Ranking Member of the Subcommittee on Health Care, District of Columbia, Census and the National Archives, is convening a forum featuring Gil Kerlikowske, the Director of the Office of National Drug Control Policy (ONDCP) and local drug-control officials to discuss the impact of Federal and localized drug prevention and treatment initiatives to combat recidivism and substance misuse.
Read more about Gray Market Investigation and Visit the Tip Line here.